ArticleAntimicrobial agents and chemotherapy2017
Nosocomial Outbreak of Extensively Drug-Resistant Acinetobacter baumannii Isolates Containing
Open access · bronzeAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 42 citations in OpenAlex.
- Molecular epidemiology, microbiological features and infection control strategies for carbapenem-resistant Acinetobacter baumannii in a German burn and plastic surgery center (2020-2022).Antimicrobial resistance and infection control · 2024Article
- Molecular Epidemiology and Genetic Characterization of Carbapenem-ResistantInfection and drug resistance · 2024Article
- Virulence Factors and Pathogenicity Mechanisms ofAntibiotics (Basel, Switzerland) · 2023Review
- Review
- Pandrug-resistantFrontiers in cellular and infection microbiology · 2023Article
- Single Nucleotide Polymorphism-Based Real-Time PCR Screening Assay for Rapid Tracking of Bacterial Infection Clusters To Complement Whole-Genome Sequencing Efforts during Outbreak Investigations.Microbiology spectrum · 2022Article
- Molecular Epidemiology of Carbapenem-ResistantMicrobial drug resistance (Larchmont, N.Y.) · 2022Article
- Article
- Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.The Journal of antimicrobial chemotherapy · 2022Article
- Human Serum Proteins and Susceptibility ofBiomedicines · 2022Article
- Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.Molecular biology reports · 2021Review
- Article
- Overexpression of Efflux Pumps, Mutations in the Pumps' Regulators, Chromosomal Mutations, and AAC(6')-Ib-cr Are Associated With Fluoroquinolone Resistance in Diverse Sequence Types of Neonatal SepticaemicFrontiers in microbiology · 2021Article
- Whole-Genome Assessment of ClinicalFrontiers in microbiology · 2021Article
- Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.Journal of molecular modeling · 2020Article
- What do we know about plasmids carried by members of the Acinetobacter genus?World journal of microbiology & biotechnology · 2020Review
- Carbapenemases: TransformingBiomolecules · 2020Review
- Multidrug-resistant Acinetobacter baumannii outbreaks: a global problem in healthcare settings.Revista da Sociedade Brasileira de Medicina Tropical · 2020Review
- Structure and Evolution ofFrontiers in microbiology · 2020Article
- Genetic Characterization of Plasmid-BornemSphere · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 7 institutions in 2 countries.
Andrea M HujerDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Paul G HigginsInstitute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
Susan D RudinDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Genevieve L BuserPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
Steven H MarshallLouis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
Kyriaki XanthopoulouInstitute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
Harald SeifertInstitute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany.
Laura J RojasLouis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
T Nicholas DomitrovicDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
P Maureen CassidyPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
Margaret C CunninghamPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
Robert VegaPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
Jon P FurunoDepartment of Pharmacy Practice, Oregon State University/Oregon Health and Science University College of Pharmacy, Portland, Oregon, USA.
Christopher D PfeifferDepartment of Hospital and Specialty Medicine, VA Portland Health Care System, Portland, Oregon, USA.
Zintars G BeldavsPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
Meredith S WrightJ. Craig Venter Institute, La Jolla, California, USA.
Michael R JacobsDepartment of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Mark D AdamsJ. Craig Venter Institute, La Jolla, California, USA.ORCID 0000-0003-3161-7460
Robert A BonomoDepartment of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA robert.bonomo@va.gov.
Louis Stokes Cleveland VA Medical Center · USOregon Health Authority · USUniversity of Cologne · DEJ. Craig Venter Institute · USOregon Health & Science University · USOregon State University · USUniversity School · US
Funding
The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7MUnderstanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6MUnderstanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9MA Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4MThe Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1I01BX001974 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BONOMO, ROBERT A. · 2013 to 2024
–ACL HHS U54CK000484BLRD VA I01 BX001974NCEZID CDC HHS U54 CK000484NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01 AI100560NIAID NIH HHS U19 AI110819
Abstract
Carbapenem antibiotics are among the mainstays for treating infections caused by
Indexed as
Acinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsCross InfectionDisease OutbreaksDNA, BacterialDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsPolymerase Chain ReactionAnti-Bacterial AgentsBacterial Proteinsbeta-lactamase OXA-237, Acinetobacter baumanniibeta-LactamasescarbapenemaseCarbapenemsDNA, BacterialAcinetobacterAcinetobacter baumanniicarbapenemaseOXA-237plasmid
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.